Helping life sciences organizations plan and execute their most important projects and change programs.
Top-tier management consulting with a global flair.
Program Management Office
Goal of a PMO is to achieve a higher set of organizational objectives by more efficient and accountable project performance.
We can design, set-up, and manage a Program Management Office to oversee your high-priority initiatives and projects.
Goal is to maximize the odds of success of your transactions, including the value they aim to create.
We can plan your integrations, set up the right governance, and manage the day-to-day so you can focus on growing the business.
Goal is to drive lasting improvement in performance and organizational health across your lines of business.
We can run impact assessments, secure stakeholder buy-in, and implement large change programs within or across business units.
Goal is to ensure optimal learning and decision-making outcomes across middle or senior management.
We can facilitate planning, brainstorming, strategy, or other workshops that are customized to your target outcomes.
Supported product strategy for a leading mRNA BiotechCo, playing Chief of Staff across multiple functions and framing strategic trade-offs for management.
Revamped the business model and investor strategy for a genetics startup so it could focus on a significantly larger target market in a more cost-effective way.
Set-up and led the PMO for the flagship manufacturing plant of a global Pharmacy, improving plant governance and project accountability.
Built a staffing model for a large biotech in order to streamline cross-functional staff involvement in clinical trials.
Jeffrey Hugh Christiansen
Jeff is a former Bain & Company consultant with a passion for managing complex projects in the life sciences. He founded ValCap Life Sciences in 2019.
Over the past 18 years, he has worked across four continents in a range of capacities, from private equity investing and capacity-building to project management and large-scale change programs.
During the Covid-19 pandemic, he worked with world-shaping organizations to support the development and commercialization of the mRNA vaccine, along the way developing an even deeper appreciation for how innovation -- and effective execution -- can deliver amazing results.
He is also an investor in -- and an occasional advisor to -- select early-stage life sciences companies.
Jeff studied at Washington University in St. Louis, Georgetown, and Oxford, and currently resides in New York City.